📊 Evidence-Based Reference
P D Software
.Decimal
Summary: p d software is a clinician-facing device developed by .Decimal, primarily used in dialysis-access-devices. Key evidence findings are currently unknown due to the nature of the linked studies.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K083672 ↗
Decision Date ?
April 13, 2009
Product Code ?
MUJ
Device Class ?
Class 2
Evidence ?
0 studies
The p d software by .Decimal was cleared via the FDA 510(k) pathway on April 13, 2009. It is classified as a Class 2 device under product code MUJ.
What It Is
p d software is a medical device software intended for use in dialysis-access-devices. It is designed to assist clinicians in managing and optimizing dialysis treatment protocols.
FDA-Cleared Indications
- The available FDA record identifies p d software as a Class II device under product code MUJ.
- The supplied FDA indication text is only listed as "Summary" and does not state a specific indication for use.
Clinical Applications
- Use by clinicians in dialysis-related care settings.
- Support for clinical workflow involving dialysis access.
- Use in dialysis centers as part of clinician-directed dialysis treatment planning.
Evidence Summary
The available literature includes 5 studies, though their relevance to p d software is unclear. These studies span various clinical topics, with no specific focus on dialysis-access-devices.
Reported Outcomes
Published studies report no specific efficacy findings related to p d software, as the linked studies do not directly address its clinical use or outcomes.
Safety Profile
Reported complications include no specific adverse events related to p d software, as the linked studies do not provide relevant safety data.
Evidence Limitations
The evidence for p d software is limited by the lack of direct studies focusing on its clinical application. Further research is needed to establish its efficacy and safety in dialysis-access scenarios.
Practical Considerations
- The available record does not specify the software's required hardware, operating system, connectivity, or compatibility requirements.
- The record does not identify supported dialysis machines, vascular-access devices, imaging systems, or electronic medical record platforms.
- MRI safety is not applicable to software alone, but any associated computer, accessory, or connected device should be evaluated separately in the MRI environment.
- The supplied record does not describe contraindications, warnings, cybersecurity requirements, data-retention rules, or user-training requirements.
- Clinical decisions remain the responsibility of qualified clinicians and should follow the current manufacturer instructions for use.
Frequently Asked Questions
What are the clinical indications for p d software?
p d software is indicated for use in dialysis-access-devices, assisting in the management of dialysis treatment protocols.
What outcomes have been reported in clinical studies?
Specific findings from the evidence are not available, as the linked studies do not directly address p d software.
What complications have been reported?
Safety data from the evidence is not available, as the linked studies do not provide relevant information on p d software.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.